The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts
Open accessAbstract
Clostridium difficile persists in hospitals by exploiting an infection cycle that is dependent on humans shedding highly resistant and infectious spores. Here we show that human virulent C. difficile can asymptomatically colonize the intestines of immunocompetent mice, establishing a carrier state that persists for many months. C. difficile carrier mice consistently shed low levels of spores but, surprisingly, do not transmit infection to cohabiting mice. However, antibiotic treatment of carriers triggers a highly contagious supershedder state, characterized by a dramatic reduction in the intestinal microbiota species diversity, C. difficile overgrowth, and excretion of high levels of spores. Stopping antibiotic treatment normally leads to recovery of the intestinal microbiota species diversity and suppresses C. difficile levels, although some mice persist in the supershedding state for extended periods. Spore-mediated transmission to immunocompetent mice treated with antibiotics results in self-limiting mucosal inflammation of the large intestine. In contrast, transmission to mice whose innate immune responses are compromised (Myd88 −/− ) leads to a severe intestinal disease that is often fatal. Thus, mice can be used to investigate distinct stages of the C. difficile infection cycle and can serve as a valuable surrogate for studying the spore-mediated transmission and interactions between C. difficile and the host and its microbiota, and the results obtained should guide infection control measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In both a human-associated microbiota43-45 and macroecological46,47 context, higher phylogenetic diversity is associated with greater ecosystem resilience and productivity.”
From Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions (2013) · cites this paper as [44]
Citations
Cites
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Evolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747
Schloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,529
Superspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,358
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,330
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,212
Woolhouse, M. E. J., Dye, C., Etard, J.-F., Smith, T., Charlwood, J. D., Garnett, G. P., Hagan, P., Hii, J. L. K., Ndhlovu, P. D., Quinnell, R. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.338 · Cited by 1,194
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2007) · The ISME Journal · doi:10.1038/ismej.2007.3 · Cited by 1,134
Stecher, B., Robbiani, R., Walker, A. W., Westendorf, A. M., Barthel, M., Kremer, M., Chaffron, S., Macpherson, A. J., Buer, J., Parkhill, J., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050244 · Cited by 1,048
Self-citationBarthel, M., Hapfelmeier, S., Quintanilla-Martínez, L., Kremer, M., Rohde, M., Hogardt, M., Pfeffer, K., Rüssmann, H., & Hardt, W.-D. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2839-2858.2003 · Cited by 1,020
Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., & Hooper, L. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808723105 · Cited by 1,019
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Asymptomatic Carriage ofClostridium difficileand Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 932
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J., Hujer, A. M., Hutton‐Thomas, R., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 691
The ClosTron: a universal gene knock-out system for the genus Clostridium
Heap, J. T., Pennington, O. J., Cartman, S. T., Carter, G. P., & Minton, N. P. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.05.021 · Cited by 663
MOLECULAR GENETICS OF SPORULATION IN BACILLUS SUBTILIS
Stragier, P., & Losick, R. M. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.297 · Cited by 647
Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W., & Kuijper, E. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592257 · Cited by 633
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2008) · Nature · doi:10.1038/nature07250 · Cited by 631
Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 592
Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 566
Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., & Young, V. B. (2009) · Infection and Immunity · doi:10.1128/iai.01520-08 · Cited by 564
The role of microbiota in infectious disease
Stecher, B., & Hardt, W. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 547
Host-induced epidemic spread of the cholera bacterium
Merrell, D. S., Butler, S. M., Qadri, F., Dolganov, N. A., Alam, A., Cohen, M. B., Calderwood, S. B., Schoolnik, G. K., & Camilli, A. (2002) · Nature · doi:10.1038/nature00778 · Cited by 534
A mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510
Sekirov, I., Tam, N. M., Jogova, M., Robertson, M. L., Li, Y., Lupp, C., & Finlay, B. B. (2008) · Infection and Immunity · doi:10.1128/iai.00319-08 · Cited by 500
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“A stable intestinal microbiota community protects the host from both indigenous and exogenous pathogens through a phenomenon termed “colonization resistance” (53, 54, 58).”
BackgroundA comparative genomic view of clostridial sporulation and physiology
Paredes, C. J., Alsaker, K. V., & Papoutsakis, E. T. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1288 · Cited by 343
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile
Wilson, K. H., Kennedy, M. J., & Fekety, F. R. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.15.3.443-446.1982 · Cited by 314
Measures to Control and PreventClostridium difficileInfection
Gerding, D. N., Muto, C. A., & Owens, R. C. (2008) · Clinical Infectious Diseases · doi:10.1086/521861 · Cited by 312
Infection control measures to limit the spread of Clostridium difficile
Vonberg, R., Kuijper, E. J., Wilcox, M. H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P. J., Colville, A., Coignard, B., Daha, T., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01992.x · Cited by 312
Lawley, T. D., Bouley, D. M., Hoy-Schulz, Y. E., Gerke, C., Relman, D. A., & Monack, D. M. (2007) · Infection and Immunity · doi:10.1128/iai.01189-07 · Cited by 303
Self-citationCroswell, A., Amir, E., Teggatz, P., Barman, M., & Salzman, N. H. (2009) · Infection and Immunity · doi:10.1128/iai.00006-09 · Cited by 279
Stabler, R. A., Gerding, D. N., Songer, J. G., Drudy, D., Brazier, J. S., Trinh, H. T., Witney, A. A., Hinds, J., & Wren, B. W. (2006) · Journal of Bacteriology · doi:10.1128/jb.00664-06 · Cited by 212
Self-citationClostridium difficile: An important pathogen of food animals
Songer, J. G., & Anderson, M. A. (2005) · Anaerobe · doi:10.1016/j.anaerobe.2005.09.001 · Cited by 211
Pathogenesis of Clostridium difficile infection
Borriello, S. P. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_3.13 · Cited by 210
Wilson, K. H. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.4.1017-1019.1983 · Cited by 188
Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?
Rupnik, M. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01687.x · Cited by 184
Gerding, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/382084 · Cited by 182
Efficacy of Hospital Cleaning Agents and Germicides Against EpidemicClostridium difficileStrains
Fawley, W. N., Underwood, S., Freeman, J., Baines, S. D., Saxton, K., Stephenson, K., Owens, R. C., & Wilcox, M. H. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/519201 · Cited by 165
Construction and analysis of chromosomal Clostridium difficile mutants
O’Connor, J. R., Lyras, D., Farrow, K. A., Adams, V., Powell, D., Hinds, J., Cheung, J. K., & Rood, J. I. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05315.x · Cited by 158
Ozaki, E., Kato, H., Kita, H., Karasawa, T., Maegawa, T., Koino, Y., Matsumoto, K., Takada, T., Nomoto, K., Tanaka, R., et al. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05376-0 · Cited by 144
The Roles of γ1 Heavy Chain Membrane Expression and Cytoplasmic Tail in IgG1 Responses
Kaisho, T., Schwenk, F., & Rajewsky, K. (1997) · Science · doi:10.1126/science.276.5311.412 · Cited by 140
Fukata, M., Breglio, K. J., Chen, A., Vamadevan, A. S., Goo, T., Hsu, D. S., Conduah, D. E., Xu, R., & Abreu, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1886 · Cited by 130
Science and pragmatism in the treatment and prevention of neutropenic infection
Klastersky, J. A. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_4.13 · Cited by 129
In Vivo Bioluminescence Imaging of the Murine Pathogen Citrobacter rodentium
Wiles, S., Pickard, K., Peng, K.-T., Macdonald, T., & Frankel, G. (2006) · Infection and Immunity · doi:10.1128/iai.00848-06 · Cited by 126
Dobson, G., Hickey, C., & Trinder, J. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1754-7 · Cited by 101
Clostridium difficile in gnotobiotic mice
Onderdonk, A. B., Cisneros, R. L., & Bartlett, J. G. (1980) · Infection and Immunity · doi:10.1128/iai.28.1.277-282.1980 · Cited by 96
Drudy, D., Harnedy, N., Fanning, S., O’Mahony, R., & Kyne, L. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01634.x · Cited by 81
Clostridium difficile infection
Kuipers, E. J., & Surawicz, C. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60635-2 · Cited by 77
Modelling infectious disease — time to think outside the box?
Wiles, S., Hanage, W. P., Frankel, G. M., & Robertson, B. D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1386 · Cited by 65
Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile
Bishara, J., Peled, N., Pitlik, S. D., & Samra, Z. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.01.033 · Cited by 55
Infection of Hamsters with Historical and Epidemic BI Types ofClostridium difficile
Razaq, N., Sambol, S. P., Nagaro, K. J., Zukowski, W. E., Cheknis, A. K., Johnson, S., & Gerding, D. N. (2007) · The Journal of Infectious Diseases · doi:10.1086/523106 · Cited by 54
Clostridium difficile: from obscurity to superbug
Brazier, J. S. (2008) · British Journal of Biomedical Science · doi:10.1080/09674845.2008.11732796 · Cited by 36
Interaction of Enteric Bacterial Pathogens with Murine Embryonic Stem Cells
Yu, J., Rossi, R., Hale, C., Goulding, D., & Gordon Dougan, B. (2008) · Infection and Immunity · doi:10.1128/iai.01003-08 · Cited by 35
Self-citationBohnhoff, M., Bl, D., & Cp, M. (2002) · PubMed · Cited by 35
Clostridium difficile and acute respiratory distress syndrome
Jacob, S. S., Sebastian, J. C., Hiorns, D., Jacob, S., & Mukerjee, P. K. (2004) · Heart & Lung · doi:10.1016/j.hrtlng.2004.04.003 · Cited by 29
Riley, T. V., Brazier, J. S., Hassan, H. H., Williams, K., & Phillips, K. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800067832 · Cited by 29
Clostridium difficilecausing acute renal failure: Case presentation and review
Arrich, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1245 · Cited by 21
Vernet, A. R., Corthier, G., Dubos, F., & Parodi, A.-L. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2123-2127.1989 · Cited by 19
Colitis Associated with Clostridium difficile in Specific-Pathogen-Free C3H-scid Mice
Kawano, A., Ikeda, M., Riichirou, I., Akiko, K., Watanabe, K., Tatsuo, H., Kokubo, T., & MATSUSHITA, S. (2007) · Journal of Veterinary Medical Science · doi:10.1292/jvms.69.973 · Cited by 10
Research works printed but not linked: 1
- Invasion ecology 2007 vol. 1
Cited by
Sorted by citations
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Impacts of biodiversity on the emergence and transmission of infectious diseases
Keesing, F., Belden, L. K., Daszak, P., Dobson, A., Harvell, C. D., Holt, R. D., Hudson, P., Jolles, A., Jones, K. E., Mitchell, C. E., et al. (2010) · Nature · doi:10.1038/nature09575 · Cited by 2,043
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Self-citationControl of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Metadata
- Authors
- Lawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., Fairweather, N. F., Wren, B. W., Parkhill, J., & Dougan, G.
- Affiliations
- Microbial Pathogenesis Laboratory
- Wellcome Sanger Institute (GB)
- University of London (GB)
- Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
- Imperial College London (GB)
- Corresponding author
- Lawley, Trevor D.
- ORCID
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2009-09
- Volume
- 77
- Issue
- 9
- Pages
- 3661-3669
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC2737984
- OpenAlex
- W2125181303
- Cited by
- 349
- References
- 66
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 15 · 2023: 16 · 2022: 9 · 2021: 29 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 14 · 2016: 21 · 2015: 34 · 2014: 30 · 2013: 31 · 2012: 24
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Royal Society
- Engineering and Physical Sciences Research Council (EP/E500412/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- Clostridium difficile, asymptomatic carriage, antibiotic therapy, gut microbiota, MyD88 knockout mice, innate immunity, mucosal inflammation, infection cycle, infection control, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Carrier State, Enterocolitis, Pseudomembranous, Female, Intestines, Mice, Inbred C57BL, Spores, Bacterial, Clostridioides difficile, Immunocompromised Host, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review